Intralytix has received a US Army phase I STTR grant to support the development of a new treatment to manage the Shigella infection, a cause of diarrheal disease that is of particular concern to the army.

The post Army Awards Contract to Develop Diarrhoea Treatment appeared first on Army Technology.